Prospect for commercialization of domestic AIDS vaccines looks bright

Published: 2002-10-08 06:58:00

Updated: 2002-10-08 06:58:00

The possible commercialization of AIDS vaccines in Korea will be available in parallel with the intensive research of domestic scientists, the Korean Intellectual Property Office (KIPO) said recently.

According to data released by the KIPO, the patent applications related to AIDS vaccines tota...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK